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Abstract
INTRODUCTIONS—To assess agreement of mammography interpretations by community
radiologists with consensus interpretations of an expert radiology panel, to inform approaches that
improve mammography performance.
METHODS—From six mammography registries, 119 community-based radiologists were
recruited to assess one of four randomly assigned test sets of 109 screening mammograms with
comparison studies for no recall or recall, giving the most significant finding type [mass,
calcifications, asymmetric density or architectural distortion] and location. The mean proportion of
agreement with an expert radiology panel was calculated by cancer status, finding type, and
difficulty level of identifying the finding at the woman, breast, and lesion level. We also examined
concordance in finding type between study radiologists and the expert panel. For each finding
type, we determined the proportion of unnecessary recalls, defined as study radiologist recalls that
were not expert panel recalls.
RESULTS—Recall agreement was 100% for masses and for exams with obvious findings in both
cancer and non-cancer cases. Among cancer cases, recall agreement was lower for lesions that
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were subtle (50%) or asymmetric (60%). Subtle non-cancer findings and benign calcifications
showed 33% agreement for recall. Agreement for finding responsible for recall was low,
especially for architectural distortions (43%) and asymmetric densities (40%). Most unnecessary
recalls (51%) were asymmetric densities.
CONCLUSION—Agreement in mammography interpretation was low for asymmetric densities
and architectural distortions. Training focused on these interpretations could improve
mammography accuracy and reduce unnecessary recalls.
Keywords
mammography; breast cancer; screening; agreement
INTRODUCTION
The effectiveness of screening mammography depends on the accuracy of image
interpretation. However, the interpretive performance of US radiologists in community
practice varies widely for screening mammography [1]. Notable interobserver variability is
seen, even when interpreting the same mammographic images [2-7]. Most studies
comparing radiologists’ interpretations of screening mammogram test sets have focused on
agreement of the Breast Imaging and Reporting Data System [BI-RADS®] assessment [4, 6,
7-9]. Berg et al. [5] found considerable variability in the assessment of 103 screening
mammograms interpreted by five experienced radiologists. Ciatto et al. [6] and Kerlikowske
et al. [4] reported moderate interobserver agreement in studies of 100 examinations
interpreted by 12 radiologists, and 2616 mammograms interpreted by two radiologists,
respectively. Elmore et al. [3], Lazarus et al. [9], Venta et al, [10] and Skaane, et al. [11]
reported substantial interobserver variation in studies of 50 to 1147 mammograms, with 5 to
10 interpreting radiologists.
Agreement of mammography interpretations by finding type (calcification, mass, asymmetry
or architectural distortion) and case assessment difficulty has not been well characterized.
Berg et al. examined agreement of five radiologists experienced in mammography for lesion
classification and defining features and found high interobserver agreement (Kappa=0.75)
for lesion classification, but not for features and management [5]. However, this prior study
was limited by small sample size and lack of an expert consensus standard. Determining
which mammographic findings have poor agreement with a well-defined standard could
identify areas of focus for interventions aimed at improving interpretive accuracy.
The purpose of this study was to assess agreement between mammography interpretations of
community radiologists and a gold standard, defined as consensus interpretations of an
expert panel. We hypothesized that certain findings or features would be mainly responsible
for lack of agreement. These would be potential areas to target for improving mammography
performance. Our study includes the largest number of participating radiologists to date for a
mammography interpretation agreement study. We analyzed variability in interpretation of
screening mammograms by finding and by difficulty of identification, examining agreement




This study was conducted within six breast screening registries of the National Cancer
Institute-funded Breast Cancer Surveillance Consortium (BCSC): Carolina Mammography
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Registry, Group Health Surveillance Project in Washington State, New Hampshire
Mammography Network, San Francisco Mammography Registry, New Mexico
Mammography Project, and Vermont Breast Cancer Surveillance System [13, 14].
Radiologists interpreting mammography at BCSC facilities between January 2005 and
December 2006 were invited to participate. In addition, we invited 103 radiologists from
outside the BCSC in Oregon, Washington, North Carolina, San Francisco, and New Mexico.
Of the 469 invited radiologists, 148 (31.6%) provided informed consent and 119 (80.4%) of
these completed the study. Radiologists received up to eight Category I continuing medical
education credits for interpreting a test set. Each site received Institutional Review Board
approval for study activities. Active or passive consent and/or waivers are obtained at each
site from women receiving mammograms. Identities of women, physicians, and facilities are
protected by a Federal Certificate of Confidentiality and other protections. All procedures
comply with the Health Insurance Portability and Accountability Act.
Test set development
Test set development is described in detail elsewhere [15]. Briefly, we developed four test
sets differing by cancer prevalence and case difficulty of 109 mammograms each, sampled
from 130 screening mammograms interpreted by BCSC radiologists from 2000 to 2003.
Some of the 130 cases were included in one or more test sets based on the desired
composition of each test set. For example, test sets 1 and 2 contained 13% subtle cases,
while test sets 3 and 4 contained 30% subtle. In order to achieve the needed proportions,
some of the subtle cases were used in two or more of the test sets. We used screening
examinations for women aged 40-69 years with a previous mammogram within the prior
11-30 months that could be used for comparison views. We excluded women with a history
of breast cancer or breast augmentation. Each test set case consisted of craniocaudal (CC)
and mediolateral oblique (MLO) views of each breast (4 views per woman for each
screening and comparison examination).
Custom-designed software for viewing images and collecting interpretations was created in
collaboration with the American College of Radiology (ACR), whose staff professionally
digitized and uploaded the films into the software on DVDs.
Three expert radiologists participated in test set development, all of whom are senior
radiologists in academic medical centers who teach and specialize in breast imaging, and
have all been past presidents of the Society for Breast Imaging (SBI) and/or recipients of
SBI’s Gold Medal award. The experts reviewed 320 digitized screening studies and exclude
those with poor image quality or marks that were not removed when digitized, resulting in
the 130 studies of the test set. Before administering the test, each digitized mammogram was
independently reviewed by the three expert radiologists using the test set software. Each
expert made an independent assessment, indicating whether the patient should be recalled
for a finding visible on the digitized image. Each expert identified the most significant
finding and classified that finding as a mass, calcification, asymmetric density, or
architectural distortion and assigned a level of difficulty of finding identification (obvious,
intermediate, subtle). Consensus expert opinion was taken to be the agreement of at least
two of three experts for each measure. A consensus meeting resolved 68 cases for which all
three expert radiologists disagreed. All finding types and descriptors used in this study were
based on this expert consensus. For each finding recalled by the panel of exerts, one expert
defined the lesion location (“region of interest”) by drawing a rectangle around it.
Test Set Administration
Consenting radiologists were randomized to one of the four test sets using a block
randomization scheme with stratification by BCSC registry (or site for non-BCSC
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radiologists) and by whether the radiologist had interpreted at least 30 breast cancer cases in
the BCSC database. This ensured sufficient power to examine clinical performance
measures related to test set performance as part of the larger study.
Test set DVDs were sent to each consenting radiologist with their test set assignment and an
instruction sheet for software system registration. Radiologists used a computer of their
choice, or a laptop provided by the study, with a DVD reader and display requirements that
allowed viewing two images concurrently, with sufficient resolution.
Radiologists were instructed to interpret the images as they would in clinical practice, except
that they were requested to record only the most significant finding, if any. Radiologists
were informed that the test sets had been cancer-enriched but the specific prevalence of
cancer cases was not revealed. For each case, radiologists indicated whether they would
recall the case using the software, which defined recall/no recall based on the American
College of Radiology BI-RADS lexicon definition of recall = codes 0, 4 and 5; and no
recall= codes 1 and 2. For recall cases, radiologists selected a finding type (mass,
calcification, asymmetric density, or architectural distortion), and indicated the location by
clicking on the image(s), which translated the location into coordinates stored by the
software.
Outcome Measures
Our main outcome measure was case assessment (recall/no recall). Results were stratified by
cancer status of cases. Cancer cases had either ductal carcinoma in situ or invasive breast
cancer diagnosed within one year of the mammogram. Non-cancer cases did not have a
breast cancer diagnosis within 24 months after the mammogram. We defined the recall of a
non-cancer case as appropriate if the expert panel determined additional imaging was
necessary because the chance of cancer based on the screening results was sufficiently high.
Unnecessary recalls were cases that did not require additional work-up according to the
expert panel.
Analyses
Analyses of recall agreement were conducted at the woman, breast, and lesion level to help
understand the level at which interpretive agreement is most problematic and may have the
most clinical impact and to refine the agreement to test whether it is important to tie
agreement to the actual lesion vs. identifying the correct breast. A study radiologist was
considered as recalling the same breast as the experts if the finding location indicated by the
radiologist was in the same breast as the region of interest indicated by the experts. A study
radiologist was considered to recall the same significant breast lesion as the experts if the
finding location indicated by the radiologist was within the gold standard region of interest.
We calculated the proportion of mammograms recalled by study radiologists separately by
cancer status, the difficulty level of identifying a finding, and lesion type. More specifically,
we calculated the percent recall (agreement with expert consensus) for each study
radiologist, separately by cancer status and case characteristics (difficulty and finding type
as defined by the expert panel), and report the median and interquartile range (IQR) of study
radiologist percent agreement with the gold standard. We graphed the proportion of cases
recalled by 0-25%, 26-50%, 51-75%, and 76-100% of study radiologists, separately by case
difficulty and finding type for cancer cases and appropriate recalls.
We examined whether consistent nomenclature was used to classify abnormal findings, or
whether there was variability in the finding type classification when the same lesion was
recalled. To do this, we report the distribution of finding type classifications given by the
study radiologists when they recalled the same lesion as the expert panel, stratified by the
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gold-standard finding of the expert panel and by level of difficulty. We calculated the
distribution of finding type for all cases recalled by the community radiologists in relation to
whether the experts recalled it.
RESULTS
The majority of participating radiologists (64%) reported interpreting mammography for
more than 10 years (Table 1). Few had breast fellowship training (13%) or self-identified as
a breast specialist (8%), and most were not affiliated with an academic institute (86%). Over
half (51%) of participating radiologists reported working three or more days a week in
breast imaging and 63% reported interpreting an average of ≥1000 mammograms per year
during the previous 5 years.
Variation in recall among community radiologists
The median percent of mammograms recalled by the study radiologists varied by level of
difficulty and finding type (Table 2). Overall, a median of 80% (IQR: 70-87%) of cancers
were recalled at the woman level, 73% (IQR: 67-83%) at the breast level, and 67% (IQR:
55-73%) at the lesion level (Table 2). At the woman level, recall was much less likely for
subtle cancers (50%; IQR: 40-75%) than intermediate (86%; IQR: 69-100%) or obvious
(100%; IQR: 83-100%). The median percent of subtle cancers recalled decreased at the
breast and lesion levels (Table 2). Among cancers, asymmetric densities (as defined by the
experts) had the lowest median percent recall (woman level: 60%; IQR: 50-75%), with 50%
recalled at the lesion level (IQR: 40-75%). Masses were the most likely to be recalled, with
100% recalled at the woman (IQR: 83-100%) and breast level (IQR: 78-100%) (Table 2).
Findings for non-cancer cases with lesions that were appropriate recalls were similar to
cancer cases: subtle benign lesions were recalled less often than intermediate and obvious
lesions (Table 2). Benign calcifications recalled by the experts were “appropriately” recalled
only one-third of the time by study radiologists (33% median recall; IQR: 33-67%). The
median rate of unnecessary recall among non-cancers was 26% (IQR: 16-33%).
Variation between community radiologists and the expert panel in recall recommendation
We further examined agreement in recall recommendations between the study radiologists
and the expert panel. We report the percent of readers who recalled cases, stratified by case
characteristics. Overall, an increasing level of difficulty reduced observed agreement in
recall, as did measuring agreement at the lesion level for both cancers and non-cancers
(Figures 1a and 1c). For non-cancers, agreement between the majority of study radiologists
and the expert panel was markedly lower for appropriate recall of intermediate and subtle
lesions than for obvious lesions (Figure 1c). For recalling asymmetric densities that were
cancers, majority agreement with the expert panel was 44% at the lesion level (Figure 1b).
However, at the woman level, the majority of radiologists (51% or higher) agreed with the
expert panel for most finding types (mass: 100%, calcification: 83%, asymmetric densities:
77%, and architectural distortion 100%). For recall of non-cancer lesions, the majority of
radiologists agreed with the expert panel only for masses (100% for woman and breast level)
(Figure 1d). For recall of non-cancer cases at the woman level, majority agreement with the
expert panel was relative low for calcifications (33%), asymmetric densities (66%), and
architectural distortions (50%) (Figure 1d).
We found an overall high concordance in nomenclature for masses and calcifications (79.9%
and 91.7%, respectively), with much lower concordance for asymmetric densities (40.7%)
and architectural distortion (45.3%) (Table 3). For subtle cases, lack of concordance for
asymmetries and architectural distortion appeared to be caused by classification of
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asymmetric densities as distortions and vice versa (Table 3a). For intermediate cases, both
asymmetric densities and architectural distortions were frequently classified as masses
(46.1% and 32.0%, respectively) (Table 3b). Obvious cases showed high concordance for all
finding types (Table 3c).
The goal of breast screening effectiveness research is achieving good sensitivity with low
false positive rates, for example by discovering ways to minimize unnecessary recalls.
Therefore, to determine if certain findings were associated with more unnecessary recalls,
we examined appropriate and unnecessary recalls of non-cancers by finding type (Table 4).
The most frequent appropriate recalls, defined as agreement with the expert panel, were for
masses (50%). Calcifications accounted for 14% of appropriate recalls, and only 7% of
unnecessary recalls. Asymmetric densities were 40% of all non-cancer findings, but only
26% of appropriate recalls and 51% of unnecessary recalls. Architectural distortions
accounted for only 10% of appropriate recalls and 15% of unnecessary recalls.
DISCUSSION
This test-set study is the largest to date to examine agreement between radiologist recall and
a consensus-derived gold standard interpretation. It is the first to examine the factors of
interpretive difficulty and finding type at the woman, breast, and lesion level. As expected,
agreement was high for obvious findings, and markedly lower for subtle findings, most
notably among non-cancer cases. Overall, agreement by finding type was relatively high for
cancer cases compared to non-cancers, but calcifications, architectural distortions, and
asymmetries all contributed to lower agreement. Much of the difference in agreement
appeared to be due to nomenclature, particularly for architectural distortion and
asymmetries. Most unnecessary recalls by the participating radiologists were for
asymmetries.
Our analysis of woman-, breast-, and lesion-level findings suggested that radiologists may
arrive at the same recall decision even if they are not basing their decision on the same
lesion. We also found that woman- and breast-level agreement was consistently stronger
than lesion-level. The implications of these findings may be a similar clinical course for any
cases for which there is at least breast-level, but particularly lesion-level agreement, because
in radiologists recommend follow-up that is pursued to a final interpretation. Accuracy at the
breast level may indeed lead to appropriate work-up and treatment, however there will be
times when the lesion is benign or a cancer lesion is missed, or when a more efficient
workup and/or better clinical course would result if the specific lesion is correctly identified
on screening.
Nonetheless, specific lesions may require particular courses of clinical care, and differences
in finding type may alter management. An advantage of our multilevel approach is that we
were able to identify the most challenging finding types, which will inform strategies to
improve interpretive performance. By focusing on non-mass findings, particularly in
intermediate and subtle cases, responsive educational interventions can be designed to yield
clinically important improvements.
This study provides a unique perspective on variability in mammography interpretation by
measuring agreement with a well-defined standard interpretation. Several other studies
examined interobserver agreement, particularly for assessing performance and use of the BI-
RADS lexicon [5-7, 16]. A focus on recall/no recall, as in this study has high clinical
relevance as it determines whether a woman will undergo further follow-up, which provides
additional information for a final assessment. Previous studies of lesion agreement focused
on detailed characterization of mass characteristics [5, 16], and we found the highest level of
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agreement between study radiologists and the expert panel for masses. Our results showed
the lowest agreement for architectural distortion and asymmetric densities, consistent with
studies that suggest that classification of finding type rather than detection reduces
interobserver agreement [5, 6, 16].
Several important aspects of this study should be noted in interpreting the results. First,
radiologists were in a testing situation rather than a usual clinical care setting. Gur et al.
reported significantly lower performance level among radiologists (n=9) in the laboratory
compared to the clinic, and lower inter-reader dispersion in a clinical setting [17]. In
contrast, another study comparing clinical and test-set performance in 27 mammographers
found no correlation among settings and results [18]. Our study used the same cases and test
situation for the gold standard interpretations and the study radiologists’ interpretations,
possibly providing a more valid comparison. Our findings in a testing environment are
congruent with Venkatesan, et al., who examined the positive predictive value (PPV) of
specific findings in actual practice and showed that asymmetries had the lowest PPV, i.e.,
that most recalled findings were benign [19].
Radiologists were instructed to report the most significant finding for the mammogram. In
some cases, although study radiologists noted the same lesions as the expert panel as
indicated by the “clicks” on the screen, they differed with the gold standard interpretation in
assignment of the “most significant” lesion; i.e. the final lesion type ascribed to the case.
This speculation also is consistent with the greater agreement at the woman level, i.e.,
although there was greater disagreement in which finding was most significant, the clinical
importance assigned to the different findings led to the same action.
The images were converted from analog to digital, with some loss of image quality. The
digitization process used in the study (from the American College of Radiology) is the same
as was used for the Committee on Mammography Interpretive Skills Assessment (COMISA)
exam (now MCR - Mammographic Case Review); however in our study, cases with findings
of interest were not specifically chosen based on feature image quality. Although all
participants were invited to use a study laptop, participating radiologists may have reviewed
the cases on personal computers, although the software program required minimum viewing
criteria.
A major strength of our study is the relatively large number of participating radiologists. In
addition, the custom-made software contained important features for viewing and
interpreting, including availability of comparison films, pan and zoom features, and a
standard mammography image set for each exam (left and right MLO, left and right CC, and
comparison images). Another key strength was the development of gold standard
interpretations through a rigorous consensus process with three nationally recognized
mammography experts. We had an explicit goal of creating a test set representative of
clinical practice. Thus, we randomly selected exams from clinical practice, thereby
including some difficult cases, which introduced more variability, but increased
generalizability.
This study provides important insights into the types of mammographic cases that contribute
the most to interpretation variability. By understanding the extent to which case difficulty
and finding type affects interpretive agreement, we can develop targeted training modules
and educational interventions that yield the greatest improvement in radiologist interpretive
performance. Our analysis of mammography interpretation agreement between radiologists
and an expert panel suggests that mammography training should focus on identification and
correct interpretation of asymmetric densities and architectural distortion.
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- Interpretive agreement with an expert panel was high for cancer cases, but
less so for non-cancers, particularly for subtle lesions and calcifications,
architectural distortions and asymmet-ric densities.
- Asymmetric densities accounted for half of all unnecessary recalls.
- Differences in agreement were often due to nomenclature of a given lesion
- Subtle, non-mass lesions are the most challenging to interpret clinically and
may benefit from targeted training strategies
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Percent of participating radiologists recalling cases based on level of lesion difficulty and
finding type [mass, calcification, asymmetric density, and architectural distortion].
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Table 1






 Yes 9 (7.6%)
 No 110 (92.4%)
Fellowship training in breast or women’s imaging
 Yes 15 (12.6%)
 No 104 (87.4%)
Main practice with academic radiology group
 Yes 17 (14.3%)
 No 102 (85.7%)
Average days per week working in breast imaging
 1 day or less 34 (28.6%)
 2 days 24 (20.2%)
 3 days 28 (23.5%)
 4 days 15 (12.6%)
 5 days 18 (15.1%)
Years interpreting mammography
 1-5 years 25 (21.0%)
 6-10 years 18 (15.1%)
 11-20 years 51 (42.9%)
 21-30 years 17 (14.3%)
 31 years or more 8 (6.7%)
Average number of mammograms interpreted per year during
the last 5 years
 Don’t know 29 (24.4%)
 Up to 1000 15 (12.6%)
 1001 to 2500 38 (31.9%)
 2501 to 4000 15 (12.6%)
 4001 or more 22 (18.5%)
Mammography examinations interpreted per week
 Up to 10 8 (6.7%)
 11-49 25 (21.0%)
 50-99 36 (30.3%)
 100-199 31 (26.0%)
 200 or more 19 (16.0%)
Self-described ability to perceive and determine importance
of mammographic findings
 Not sure 3 (2.5%)
 Below average 2 (1.7%)

















 Average 53 (44.5%)
 Above average 50 (42.0%)
 Expert 11 (9.2%)
AIM-BCSC test set number
 1 30 (25.2%)
 2 34 (28.6%)
 3 28 (23.5%)
 4 27 (22.7%)
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Table 2
Composition of the four AIM test sets and percent of cases recalled by the community radiologists.*
†
Percent recalled: median




Overall 43 NA NA
Cancers 80 73 67
  Difficulty
   Obvious 100 100 83
   Intermediate 86 86 71
   Subtle 50 40 25
  Expert finding type
   Mass 100 100 83
   Calcification 82 70 64
   Asymmetric densities 60 50 50
   Architectural distortion 80 80 50
No cancer 34 NA NA
 Appropriate recalls 67 57 43
  Difficulty-appropriate recalls
   Obvious 100 100 67
   Intermediate 75 67 50
   Subtle 33 17 17
  Expert finding type-appropriate
recalls
   Mass 100 100 67
   Calcification 33 33 33
   Asymmetric densities 56 44 33
   Architectural distortion 50 50 33
 Other non-cancers 26 NA NA
*
Radiologists labeled each case in the test set as a recall (BI-RADS assessment 0, 4, or 5: Needs additional imaging) or a non-recall (BI-RADS
assessment 1 or 2: Negative or benign).
†
The number of radiologists that interpreted each case varies across cases.
‡
Breast level percents are the percent of cases in each category for which the radiologist recalled the same breast as did the experts (not applicable
for films not recalled by the experts).
§
Lesion level percents are the percent of cases in each category for which the radiologist recalled the same lesion/region as did the experts (not
applicable for films not recalled by the experts).
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Table 3
Distribution (%) of community radiologist finding types for cases in each category of
expert finding type







 mass 79.9 1.0 12.6 6.6
 calcification 7.0 91.7 0.8 0.5
 asymmetric density 40.4 4.1 40.7 14.7
 architectural distortion 25.0 9.3 20.4 45.3
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Table 3a
Distribution (%) of finding types: Subtle cases







 mass* NA NA NA NA
 calcification 0.0 98.4 0.0 1.6
 asymmetric density 21.4 1.3 38.4 39.0
 architectural distortion 21.6 0.0 52.9 25.5
*
No subtle lesions were labeled a mass by the experts.
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Table 3b
Distribution (%) of finding types: Intermediate cases







 mass 75.5 1.0 15.0 8.5
 calcification 0.7 98.9 0.0 0.4
 asymmetric density 46.5 5.0 41.5 7.0
 architectural distortion 32.1 14.6 16.1 37.3
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Table 3c
Distribution (%) of finding types: Obvious cases







 mass 90.6 0.9 6.6 1.9
 calcification 12.4 85.7 1.5 0.5
 asymmetric density
† NA NA NA NA
 architectural distortion 9.5 0.0 19.6 71.0
†
No obvious lesions were labeled an asymmetric density by the experts.
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Table 4






 Appropriate recalls: recalled by experts* 0.50 0.14 0.26 0.10
 Unnecessary recalls: not recalled by experts 0.27 0.07 0.51 0.15
 All non-cancer cases 0.37 0.10 0.40 0.13
*
Radiologists were instructed to locate and label the single most important lesion for all recalled cases. For non-cancer cases recalled by the
experts, the expert finding type label may refer to a different location than that identified by the community radiologist recalling the case.
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